Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Marriott

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Expert Opinion on Investigational Drugs|August 1, 1997
TNF-alpha antagonists: monoclonal antibodies, soluble receptors, thalidomide and other novel approachesJ B Marriott
Clinical and Experimental Immunology|August 1, 1993
Antimitochondrial autoantibodies in anti-glomerular basement membrane diseaseJ B Marriott, D B Oliveira
Clinical and Experimental Immunology|March 1, 1994
Serial functional affinity of autoantibodies in anti-glomerular basement membrane diseaseJ B Marriott, D B Oliveira
Immunology Today|November 24, 1999
Thalidomide as an emerging immunotherapeutic agentJ B Marriott, G Muller, A G Dalgleish
Journal of Autoimmunity|August 1, 1994
Anti-phospholipid antibodies in the mercuric chloride treated brown Norway ratJ B Marriott, F Qasim, D B Oliveira
Clinical and Experimental Immunology|July 27, 2001
Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophagesJ B Marriott, I A Clarke, A G Dalgleish
Expert Opinion on Biological Therapy|December 1, 2001
Immunotherapeutic and antitumour potential of thalidomide analoguesJ B Marriott, G Muller, D Stirling, et al.
British Journal of Cancer|March 29, 2000
Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resectionA G Heriot, J B Marriott, S Cookson, et al.
Experimental Nephrology|July 1, 1995
The functional affinity and specificity of autoantibodies in animal models of anti-glomerular basement membrane diseaseJ B Marriott, F Qasim, J Reynolds, et al.
Clinical and Experimental Immunology|March 5, 1998
Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunctionM Westby, J B Marriott, M Guckian, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|August 1, 1997
TNF-alpha antagonists: monoclonal antibodies, soluble receptors, thalidomide and other novel approachesJ B Marriott
Clinical and Experimental Immunology|August 1, 1993
Antimitochondrial autoantibodies in anti-glomerular basement membrane diseaseJ B Marriott, D B Oliveira
Clinical and Experimental Immunology|March 1, 1994
Serial functional affinity of autoantibodies in anti-glomerular basement membrane diseaseJ B Marriott, D B Oliveira
Immunology Today|November 24, 1999
Thalidomide as an emerging immunotherapeutic agentJ B Marriott, G Muller, A G Dalgleish
Journal of Autoimmunity|August 1, 1994
Anti-phospholipid antibodies in the mercuric chloride treated brown Norway ratJ B Marriott, F Qasim, D B Oliveira
Clinical and Experimental Immunology|July 27, 2001
Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophagesJ B Marriott, I A Clarke, A G Dalgleish
Expert Opinion on Biological Therapy|December 1, 2001
Immunotherapeutic and antitumour potential of thalidomide analoguesJ B Marriott, G Muller, D Stirling, et al.
British Journal of Cancer|March 29, 2000
Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resectionA G Heriot, J B Marriott, S Cookson, et al.
Experimental Nephrology|July 1, 1995
The functional affinity and specificity of autoantibodies in animal models of anti-glomerular basement membrane diseaseJ B Marriott, F Qasim, J Reynolds, et al.
Clinical and Experimental Immunology|March 5, 1998
Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunctionM Westby, J B Marriott, M Guckian, et al.
Pageof 3